Moondust Ventures is excited to announce its participation in the €2.6 million Seed round of Somareality, a pioneering company at the forefront of cognitive monitoring and brain health innovation.
Somareality is redefining how we understand and track cognitive processes in real time through its development of eye-tracking-based digital biomarkers. By combining cutting-edge eye-tracking technology with neuroscience and machine learning, the company is opening new possibilities in diagnostics, brain health monitoring, and human-computer interaction.
You can find more information here.
